Most Minor Cosmetic Procedures Safe When Done by Experts

This article originally appeared here.
Share this content:
Most Minor Cosmetic Procedures Safe When Done by Experts
Most Minor Cosmetic Procedures Safe When Done by Experts

FRIDAY, Nov. 7, 2014 (HealthDay News) -- Noninvasive to minimally invasive cosmetic procedures are nearly risk-free when performed by dermatologists at practices focused on cosmetic dermatology, according to a study published online Nov. 5 in JAMA Dermatology.

Researchers examined the results of 20,399 of these procedures -- such as fillers, neurotoxins, and the use of laser and energy devices -- performed by 23 dermatologists at eight centers focused on cosmetic dermatology across the United States.

Forty-eight adverse events were reported, which translated into a rate of 0.24 percent. Overall, 36 procedures resulted in at least one adverse event, a rate of 0.18 percent. The researchers found no major complications.

"The message for patients is that if you are thinking of getting one of these procedures, you are not indulging in something drastic or high-risk," study leader Murad Alam, M.D., a professor of dermatology at the Northwestern University Feinberg School of Medicine in Chicago, said in a university news release. "The take home is these procedures are very safe and can be mixed and matched to give the individual a significant cosmetic benefit, rather than getting one big cosmetic procedure that might be risky."

Full Article
Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »